These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3829014)

  • 21. Prediction of recurrence for advanced breast cancer. Traditional and contemporary pathologic and molecular markers.
    Masood S
    Surg Oncol Clin N Am; 1995 Oct; 4(4):601-32. PubMed ID: 8535901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer.
    Schrama JG; Baars JW; Holtkamp MJ; Schornagel JH; Beijnen JH; Rodenhuis S
    Bone Marrow Transplant; 2001 Jul; 28(2):173-80. PubMed ID: 11509935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.
    Stemmer SM; Hardan I; Raz H; Adamou AK; Inbar M; Gottfried M; Merrick Y; Cohen Y; Sulkes A; Ben-Baruch N; Pfeffer RP; Brenner HJ; Rizel S
    Bone Marrow Transplant; 2003 Apr; 31(8):655-61. PubMed ID: 12692605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pilot study of primary chemotherapy with doxorubicin plus paclitaxel in women with locally advanced or operable breast cancer.
    Moliterni A; Tarenzi E; Capri G; Terenziani M; Bertuzzi A; Grasselli G; Agresti R; Piotti P; Greco M; Salvadori B; Pilotti S; Lombardi F; Valagussa P; Bonadonna G; Gianni L
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-10-S17-14. PubMed ID: 9374085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing patterns in the management of locally advanced breast cancer: a preliminary report.
    Lopez MJ; Kraybill WG; Reynolds RD; Khojasteh A
    Can J Surg; 1985 Jul; 28(4):319-21. PubMed ID: 4016605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
    Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.
    Kuerer HM; Newman LA; Buzdar AU; Dhingra K; Hunt KK; Buchholz TA; Binkley SM; Strom EA; Ames FC; Ross MI; Feig BW; McNeese MD; Hortobagyi GN; Singletary SE
    Cancer J Sci Am; 1998; 4(4):230-6. PubMed ID: 9689981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of epidermal growth factor receptor in breast cancer, from early stages to advanced disease.
    Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Branković-Magić M; Kanjer K; Gavrilović D; Mitrović L; Borojević N; Vukotić D; Spuzić I
    J Exp Clin Cancer Res; 1999 Sep; 18(3):347-55. PubMed ID: 10606181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The prognosis of bilateral breast carcinoma compared to unilateral breast tumor. 5- and 10-year follow-ups].
    Mose S; Adamietz IA; Thilmann C; Saran F; Pahnke R; Böttcher HD
    Strahlenther Onkol; 1995 Apr; 171(4):207-13. PubMed ID: 7740408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC).
    Holm NT; Abreo F; Johnson LW; Li BD; Chu QD
    Breast Cancer Res Treat; 2009 Jan; 113(2):293-9. PubMed ID: 18270814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of women who present with T4 breast cancer.
    Poole GV; Thigpen JT; Vance RB; Barber WH
    Am Surg; 2004 Aug; 70(8):662-6; discussion 666-7. PubMed ID: 15328797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of locally advanced breast neoplasms].
    Morino F; Alabiso O; Sandrucci S; Morino M; Festa V; Zanini M
    Minerva Med; 1986 Sep; 77(37):1669-72. PubMed ID: 3763037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in cell kinetics induced by primary chemotherapy in breast cancer.
    Daidone MG; Silvestrini R; Valentinis B; Ferrari L; Bartoli C
    Int J Cancer; 1991 Feb; 47(3):380-3. PubMed ID: 1993544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Locally advanced carcinoma of the breast.
    Randolph EG
    J Med Assoc Ga; 1987 Dec; 76(12):852-3. PubMed ID: 3694071
    [No Abstract]   [Full Text] [Related]  

  • 36. The cell cycle kinetics of human breast cancer.
    Straus MJ; Moran RE
    Cancer; 1980 Dec; 46(12):2634-9. PubMed ID: 7448702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival of women with locally advanced breast cancer at a teaching hospital in Lahore.
    Shafique K; Mirza SS
    J Pak Med Assoc; 2010 Dec; 60(12):1067-8; author reply 1068-9. PubMed ID: 21381567
    [No Abstract]   [Full Text] [Related]  

  • 38. Gender-related differences in repopulation and early tumor response to preoperative radiotherapy in rectal cancer patients.
    Gasinska A; Richter P; Darasz Z; Niemiec J; Bucki K; Malecki K; Sokolowski A
    J Gastrointest Surg; 2011 Sep; 15(9):1568-76. PubMed ID: 21706276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the thymidine labeling index a good prognostic marker in breast cancer?
    Sen-Oran E; Ozmen V; Bilir A; Cabioglu N; Muslumanoglu M; Igci A; Guney N; Kecer M
    World J Surg Oncol; 2007 Aug; 5():93. PubMed ID: 17705874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer.
    Fernández-Sánchez M; Gamboa-Dominguez A; Uribe N; García-Ulloa AC; Flores-Estrada D; Candelaria M; Arrieta O
    Med Oncol; 2006; 23(2):171-83. PubMed ID: 16720917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.